
Cullinan Management, Inc. Announces Business Update
February 22, 2021 Enrollment expansion in CLN-081 NSCLC EGFRex20ins Phase 1/2a trial Cullinan withdraws IND application for CLN-049 in Relapsed/Refractory AML CLN-619 IND submission planned for the second quarter of 2021 Cullinan to present at SVB Leerink …